← Eichor
Condition: Sickle Cell Nephropathy Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Sickle Cell Nephropathy

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Development of Non-Invasive Prenatal Diagnosis for Single Gene Disorders
Phase N/A · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT06147414
Targeting the Pathophysiology of Sickle Cell-Related Kidney Disease Using the SGLT2 Inhibitors, Empagliflozin
Phase 2 · 1 location(s) · University of Illinois at Chicago · NCT07175051
A Smart Phone Application to Improve Adoption of the 2024 Kidney Disease Improving Global Outcomes (KDIGO) Chronic Kidne
NA · 2 location(s) · St. James's Hospital, Ireland · NCT07561957
Cooperative Assessment of Late Effects for SCD Curative Therapies
Phase N/A · 5 location(s) · Vanderbilt University Medical Center · NCT05153967
Sickle Cell Kidney Biorepository
Phase N/A · 2 location(s) · University of Texas Southwestern Medical Center · NCT07064174
Safety, Efficacy, and Pharmacokinetics of CSL889 in Adults and Adolescents With Sickle Cell Disease During Vaso-Occlusiv
Phase 2 · 19 location(s) · CSL Behring · NCT06699849
National Registry of Rare Kidney Diseases
Phase N/A · 1 location(s) · UK Kidney Association · NCT06065852
Morphine Clearance and Glomerular Filtration in Sickle Cell Patients in Crisis in Intensive Care
NA · 6 location(s) · University Hospital, Tours · NCT07246265
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.